Login
English
Nederlands
Global Health and Pharmacotherapy
| Faculteit | Science and Engineering |
| Jaar | 2021/22 |
| Vakcode | WBFA034-03 |
| Vaknaam | Global Health and Pharmacotherapy |
| Niveau(s) | propedeuse |
| Voertaal | Engels |
| Periode | semester II b |
| ECTS | 3 |
| Rooster | rooster.rug.nl |
| Uitgebreide vaknaam | Global Health and Pharmacotherapy | ||||||||
| Leerdoelen | -The student has knowledge of factors that influence the health of individuals and populations worldwide -The student has knowledge of basic concepts of pharmacotherapy (indications, dosing, side effects, interactions, contra-indications) -The student has some insight how patients experience taking medication -The student is conversant with different treatment guidelines -The student is conversant with the role and relevance of pharmaco-epidemiology (position of observational research) -The student has knowledge of pharmacoepidemiological frequency measures (prevalence, incidence) and risk measures (relative risk, odds ratio) -The student has knowledge about the regulatory process around drug approval (EMA, CBG-MEB) -The student has knowledge about some basic aspects of pharmacovigilance |
||||||||
| Omschrijving | The course covers basic concepts of global health, pharmacotherapy, pharmacoepidemiology, pharmacoeconomics and pharmacovigilance. A number of globally relevant chronic and acute diseases are selected as case studies for the course. For each disease, patient cases are presented, some pathophysiological background of the disease, information about the impact/burden of the disease worldwide and relevant treatment guidelines. In particular we focus on the choice of medication, formulation, route of administration, given important patient characteristics including age, gender, comorbidities, contra-indications and drug interactions. This includes comparing effects and side effects of ‘old’ and ‘new’ drugs, based on evidence from clinical trials and observational studies. Other aspects which are covered in case studies are the costs of (new) drugs, global solutions such as the list of essential medicines and the life cycle of medication including the process of approval of new drugs. | ||||||||
| Uren per week | 11 | ||||||||
| Onderwijsvorm | Hoorcollege (LC), Werkcollege (T) | ||||||||
| Toetsvorm | Meerkeuze toets (MC) | ||||||||
| Vaksoort | propedeuse | ||||||||
| Coördinator | Prof. Dr. K. Taxis | ||||||||
| Docent(en) | prof. dr. T.L. Feenstra ,dr. C.C.M. Schuiling-Veninga ,Prof. Dr. K. Taxis , R. van Eekeren-Buiten ,drs. E.C. Weening | ||||||||
| Entreevoorwaarden | |||||||||
| Opmerkingen | Adapted 301121 LW | ||||||||
| Opgenomen in |
|